(casirivimab and imdevimab)
We are now administering the REGEN-COV (Regeneron) Monoclonal Antibodies Cocktail via infusion for the treatment of COVID-19.
Regeneron’s REGEN-COV Monoclonal Antibodies cocktail is used to reduce viral levels and improve symptoms in non-hospitalized COVID-19 patients. REGEN-COV is a combination of two monoclonal antibodies (REGN10933 and REGN10987) and was designed specifically to block the infectivity of SARS-CoV-2, the virus that causes COVID-19.
Monoclonal Antibodies Treatment
InfuseAble Care is the only non-emergency room / Hospital facility in the state of Arizona that is offering Regeneron’s Monoclonal Antibodies treatment for COVID-19 symptoms. It is important that our treatment is for COVID-19 symptoms that do not require hospitalization. If your symptoms are severe we recommend you seek treatment at a local hospital or emergency. Our monoclonal antibodies are delivered via injection at our infusion centers. Please call or complete the form below to schedule an appointment.
We have locations throughout the greater Phoenix metro areas as well as Lake Havasu. We can administer Regeneron Monoclonal Antibodies therapy in any of our locations. Click here to view a complete list of our infusion centers.
Information and Interest Form
REGEN-COV (aka REGN-COV2) (casirivimab and imdevimab) is an investigational medicine that may treat COVID-19. It is still being studied and there is limited information known about its safety and effectiveness. The U.S. Food and Drug Administration (FDA) has authorized the emergency use of REGEN-COV for the treatment of COVID-19 under an EUA.
For more information call us at (480) 927-3800 or complete the form below.